Additional file 3 of Costunolide is a dual inhibitor of MEK1 and AKT1/2 that overcomes osimertinib resistance in lung cancer

Authors
Publication date
6 October 2022
Publisher
Doi

    Abstract

    Supplementary Material

      Similar works

      Full text

      thumbnail-image

      Available Versions

      FigShare

      redirect
      oaioai:figshare.com:article/21293...
      Last time updated on 08/10/2022